VP Energy Efficiency Solutions, EnerNOC, Inc.
CEO and Co-Founder, Receptos
Partner, ARCH Venture Partners
Managing Director, DaggerBoard Advisors
Senior Managing Partner, Aisling Capital Fund
President and CEO, Burnham Institute for Medical Research
Founder and CEO, Acme Packet
Co-Founder and Executive Chairman, CleanTECH San Diego
|
|
[Updated: 11:05 pm ET] Regeneron Pharmaceuticals became a breakout biotech star with a new drug for treating age-related macular degeneration, the leading cause of blindness among the elderly in the U.S. Now the Tarrytown, NY-based biotech believes it’s taken... Read more »
A bit of friendly rivalry is healthy for cities with growing technology ecosystems, but sometimes they set aside the hype and find ways to collaborate. At the onset of this week’s Internet Week New York citywide festivities, representatives from 11 cities... Read more »
What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire.
Juan Enriquez may not have all the answers, but he... Read more »
David Karp’s wallet just got a lot fatter.
After a flurry of speculation over the weekend, Tumblr in New York is being acquired by Sunnyvale, CA-based Yahoo, in a deal announced early Monday at the previously reported price of $1.1 billion,... Read more »
When Astellas Pharma shuttered the labs of OSI Pharmaceuticals last week, no one felt that loss as acutely as the residents of Long Island, NY. OSI, famed for its lung cancer drug erlotinib (Tarceva), had shown that it was possible to... Read more »
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
For cities to truly thrive in this economy, fresh ideas must be cross-pollinated from beyond their borders—and New York offers its share of honey to lure in startups. This international gateway can be the place for companies to break into the... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product launches and big name hirings—and... Read more »
After much clamor about becoming a sanctuary for startups, New York faces the “now what?” stage of its growth as a tech hub.
Plans have been laid down to fill the streets with engineers—in another decade or two. But... Read more »
In a city where people know people who know people, Richard Blakeley sits at the heart of a web that connects New York’s tech community.
That enviable position stems in part from his annual Webutante Ball. While preparing for next Thursday’s... Read more »
OSI Pharmaceuticals became the home-grown beacon of Long Island, NY’s biotech scene behind the lung cancer drug erlotinib (Tarceva), which was so successful that led Japan’s Astellas Pharma to buy the company outright in a $4 billion deal in May 2010.... Read more »
The search for potential investments has led the team at ff Venture Capital in New York into strange waters.
John Frankel, a partner with the firm, says he decided to back UniKey Technologies after hearing about its founder’s appearance last year... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could have made loads of money at... Read more »
In the rush to revolutionize taxicabs, the hot new property isn’t a fancy black sedan or a network of hustling cabbies. Instead, digital entrepreneurs are suddenly racing toward the 21st century version of hitchhiking.
So-called “ridesharing” services, which enlist everyday... Read more »
It was a busy week of big promise and big moves for biotechs on the East Coast. One biotech added to a string of partnerships and awaits results from a key mid-stage study for one of its own drugs. Another signed... Read more »
Not every speech is improved by visual aids. Abraham Lincoln made do without PowerPoint at Gettysburg (though wags have tried to reimagine that), and Franklin Roosevelt’s voice on the radio in 1933 calmed a nation rattled by the Great Depression... Read more »
Biotech stars can rise and fall on the key decision of whether or not to “go it alone” and develop their drugs without the help of Big Pharma—it’s a risk that can either make or break a company. But Regado BioSciences,... Read more »
VP of Research and Special Initiatives, Google
Founding Partner, General Assembly
Professor of Molecular Biology, Rockefeller University
Co-Founder, Hunch and Founder Collective
Chair, Dept. of Biochemistry and Molecular Biophysics, Columbia University
Professor of Systems Biology, Columbia University
Professor of Molecular Biology, Rockefeller University
Founder and Managing Partner, IA Ventures
President, Rockefeller University
Professor of Media Management, Syracuse University
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
